Lexaria Bioscience Corp.
LEXX · NASDAQ
5/31/2025 | 2/28/2025 | 11/30/2024 | 8/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,791 | -$2,717 | -$2,707 | -$2,192 |
| Dep. & Amort. | $31 | $2 | $33 | -$8 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $470 | $167 | $99 | $97 |
| Change in WC | -$344 | $168 | -$168 | $174 |
| Other Non-Cash | $50 | $881 | $16 | $38 |
| Operating Cash Flow | -$3,584 | -$1,498 | -$2,726 | -$1,892 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$38 | -$43 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$19 | -$28 | $0 | -$27 |
| Investing Cash Flow | -$19 | -$28 | -$38 | -$70 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,689 | $12 | $4,345 | -$9,252 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $4,209 |
| Financing Cash Flow | $1,689 | $12 | $4,345 | $0 |
| Forex Effect | $37 | -$95 | -$3 | $2 |
| Net Chg. in Cash | -$1,877 | -$1,609 | $1,578 | -$1,959 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,469 | $8,078 | $6,500 | $8,459 |
| End Cash | $4,592 | $6,469 | $8,078 | $6,500 |
| Free Cash Flow | -$3,584 | -$1,498 | -$2,726 | -$1,961 |